An Update on the Clinical Studies Using Arimoclomol as a Potential Treatment for sIBM

preview_player
Показать описание
The ongoing Arimoclomol Clinical Trial for sIBM continues to generate a lot of questions from our community. As part of our commitment to providing the latest information on IBM research and clinical trials, we asked Dr. Mazen Dimachkie, Principal Investigator for the Phase II/III Arimoclomol Studies and Professor of Neurology and Director of the Neuromuscular Division at University of Kansas Medical Center, if he would provide us with an update.

Dr. Dimachkie was gracious enough to take the time to talk with Jerry Williams and Lynn Wilson. The presentation and Q&A were based on the sIBM community feedback and questions about the trial.
Рекомендации по теме
Комментарии
Автор

We apologize. Once the premiere ends, so does the live chatting. We will answer any questions you post.

myositissupport
Автор

Have no clue how to get onto this site.

jaynekrusman
Автор

I clicked on subscribe and had to log in but nothing is happening....

janrandall
Автор

Does the presentation just automatically start?

janrandall
Автор

Is Arimoclomol available in the United States yet?

JoeFamousOne